Multi-12/K1 Pediatric 0.2 mg (Vitamin K1 LIQUID) 0.2 MG

MULTI-12/K1 Pediatric 0.2 MG is a liquid intravenous solution containing Vitamin K1, designed for pediatric use. This formulation supports blood clotting and is commonly used in medical settings for infants and children.

Strength

0.2 MG

Pack Size

1/4 ML

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MULTI-12/K1 Pediatric 0.2 MG is primarily used to address Vitamin K1 deficiencies in children, which can affect blood clotting. It is often administered to prevent or treat bleeding disorders related to low Vitamin K1 levels. This liquid formulation is suitable for intravenous use, providing a convenient method for delivering the necessary nutrient.

Side Effects

When administered as directed, MULTI-12/K1 Pediatric 0.2 MG helps to support normal blood clotting processes. It is important to follow medical guidance to ensure proper use and to monitor for any adverse reactions.

Precautions & Warnings

MULTI-12/K1 Pediatric 0.2 MG should be handled with care, ensuring proper storage and administration. It is crucial to follow medical advice regarding dosage and usage to avoid potential complications. Always check for any signs of allergic reactions or adverse effects.

Avoid Interactions

MULTI-12/K1 Pediatric 0.2 MG may interact with certain medications, including blood thinners and other supplements. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain foods may also affect the effectiveness of Vitamin K1.

Frequently Asked Questions

MULTI-12/K1 Pediatric 0.2 MG is used to address Vitamin K1 deficiencies in children, supporting blood clotting processes.

This medication is administered intravenously, typically in a medical setting, to ensure proper dosage and administration.

The primary effect of MULTI-12/K1 Pediatric 0.2 MG is to support normal blood clotting processes in children.

Yes, it is important to follow medical advice regarding dosage and usage to avoid potential complications.

Yes, it may interact with blood thinners and other supplements, so it is important to inform healthcare providers about all medications being taken.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.